Marksans Pharma

Market Cap

9,065.77 Cr

EPS

6.92

PE Ratio

24.40

Dividend Yield

0.30 %

Industry

Healthcare

52 Week High

358.70

52 Week low

130.00

PB Ratio

3.94

Debt to Equity

0.10

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from2 analysts

Analysts have suggested that investors can buy this stock

Buy100.00 %

100.00 %

Hold0.0 %

0.0 %

Sell0.0 %

0.0 %

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,656.55	3,97,461.83	32.77	49,887.20	12.06	9,648	13.77	37.72
Divis Laboratories	5,549.75	1,47,328.43	70.79	8,184.00	0.89	1,600	64.53	39.06
Cipla	1,441.00	1,16,377.18	23.67	26,520.70	14.17	4,155	47.38	53.19
Torrent Pharmaceuticals	3,069.10	1,03,872.29	55.81	10,785.70	11.59	1,656	13.54	48.49
Dr Reddys Laboratories	1,116.35	93,149.46	17.40	28,905.40	12.36	5,578	1.69	32.01
Mankind Pharma	2,211.30	91,230.92	45.68	10,615.60	19.57	1,942	-16.38	36.72
Zydus Life Science	899.90	90,551.00	19.82	19,831.50	13.82	3,831	29.92	43.14
Lupin	1,974.75	90,087.61	31.98	20,141.50	19.94	1,936	38.82	48.40
Abbott	30,600.00	65,022.86	48.79	6,097.20	10.80	1,201	16.01	59.83
Aurobindo Pharma	1,090.00	63,307.38	18.00	29,559.20	17.55	3,169	-10.04	42.91

Growth Rate

Revenue Growth

16.55 %

Net Income Growth

18.70 %

Cash Flow Change

-2.95 %

ROE

0.47 %

ROCE

1.17 %

EBITDA Margin (Avg.)

9.54 %

Quarterly Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	171	210	256	217	210	187	187	215	192	221	274	219	199	239	268	249	257	247	264	288	335	331	360	355	336	355	370	375	433	450	467	498	497	510	550	591	577	606	653	710
Expenses	132	160	204	187	206	173	180	188	177	192	249	190	195	200	232	212	232	213	223	240	266	261	273	267	235	272	301	305	354	361	372	403	376	398	417	453	450	462	506	543
EBITDA	39	50	51	31	4	14	7	27	15	29	25	29	4	39	36	36	25	35	41	47	69	70	87	88	101	83	69	70	79	89	94	94	121	112	133	138	126	143	147	167
Operating Profit %	23 %	24 %	20 %	14 %	2 %	7 %	0 %	12 %	4 %	13 %	9 %	13 %	2 %	15 %	14 %	15 %	6 %	13 %	13 %	16 %	21 %	21 %	23 %	25 %	29 %	22 %	17 %	16 %	15 %	17 %	18 %	16 %	23 %	20 %	21 %	23 %	20 %	22 %	21 %	20 %
Depreciation	4	5	6	10	8	5	6	12	8	7	7	6	6	6	6	5	6	5	5	7	10	7	19	9	1	8	7	9	21	11	14	13	14	14	18	22	21	20	20	21
Interest	1	3	3	2	2	1	1	2	2	2	3	2	4	2	3	2	2	2	3	2	2	2	2	2	3	1	2	1	5	2	3	2	2	2	2	3	5	3	3	3
Profit Before Tax	36	45	43	19	0	7	-0	13	-1	20	15	21	-6	30	28	30	17	28	34	38	58	61	66	78	97	75	60	60	53	76	78	79	104	97	114	113	100	120	125	143
Tax	10	13	7	-0	4	2	-1	2	2	5	4	4	1	6	7	4	7	5	8	9	15	12	15	19	18	12	14	12	23	16	18	17	22	26	30	30	23	31	27	38
Net Profit	26	32	36	19	-4	5	1	12	-3	14	10	18	-7	25	21	25	10	23	26	30	43	49	51	59	80	63	46	48	30	60	60	62	83	70	84	83	78	89	98	105
EPS in ₹	0.61	0.77	0.85	0.44	-0.14	0.11	0.02	0.24	0.00	0.33	0.23	0.41	-0.17	0.58	0.48	0.60	0.21	0.52	0.63	0.71	1.00	1.20	1.21	1.42	1.93	1.51	1.11	1.20	0.69	1.46	1.52	1.56	1.97	1.52	1.84	1.84	1.73	1.96	2.13	2.31

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	676	722	752	729	804	903	1,229	1,640	2,190	2,681
Fixed Assets	166	270	267	279	270	303	309	428	486	776
Current Assets	509	440	484	449	531	594	903	1,201	1,675	1,863
Capital Work in Progress	0	0	0	0	0	0	12	3	10	9
Investments	0	0	0	0	0	0	0	0	1	27
Other Assets	510	453	485	450	534	600	908	1,209	1,694	1,869
Total Liabilities	676	722	752	729	804	903	1,229	1,640	2,190	2,681
Current Liabilities	286	259	296	233	233	229	299	356	341	390
Non Current Liabilities	2	0	16	16	18	25	25	61	84	205
Total Equity	388	463	440	480	553	649	905	1,223	1,765	2,086
Reserve & Surplus	326	401	393	430	502	595	846	1,068	1,700	2,020
Share Capital	53	53	41	41	41	41	41	41	45	45

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	138	-150	-10	15	-7	60	119	94	176	21
Investing Activities	-33	-123	-21	-39	-14	-60	-45	-84	-259	-141
Operating Activities	155	31	14	50	27	233	179	99	237	230
Financing Activities	17	-58	-4	3	-21	-114	-15	80	198	-69

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Jan 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	48.25 %	48.25 %	48.25 %	48.25 %	48.25 %	48.25 %	48.60 %	49.00 %	43.80 %	43.85 %	43.85 %	43.85 %	43.85 %	43.85 %	43.87 %	43.87 %	43.87 %
FIIs	1.00 %	0.59 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	10.88 %	10.88 %	10.88 %	10.88 %	10.88 %	15.57 %	18.60 %	21.31 %	21.96 %
DIIs	0.09 %	0.34 %	0.34 %	0.34 %	0.46 %	0.95 %	0.95 %	0.96 %	0.87 %	1.46 %	3.65 %	3.15 %	3.82 %	5.17 %	3.75 %	4.10 %	4.30 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.15 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	41.50 %	41.71 %	42.41 %	42.47 %	41.36 %	40.77 %	39.76 %	39.69 %	35.19 %	34.42 %	32.36 %	32.12 %	30.80 %	30.91 %	29.47 %	26.77 %	26.24 %
Others	9.15 %	9.11 %	9.00 %	8.94 %	9.78 %	10.04 %	10.69 %	10.34 %	9.25 %	9.39 %	9.25 %	10.00 %	10.64 %	4.49 %	4.31 %	3.95 %	3.63 %
No of Share Holders	0	1,35,271	1,88,888	2,01,451	2,14,998	2,20,090	2,21,359	2,17,743	2,13,123	1,98,382	1,88,447	2,07,937	2,37,377	2,54,699	2,35,500	2,48,845	2,59,813